Poultry coccidiosis vaccine on horizon.Poultry farmers and chicken lovers take heart. Scientists are one step closer to developing a vaccine against coccidiosis coccidiosis /coc·cid·i·o·sis/ (kok-sid?e-o´sis) infection by coccidia. In humans, applied to the presence of Isospora hominis or I. belli in stools; it is often asymptomatic, rarely causing a severe watery mucous diarrhea. , a parasitic disease that costs the U.S. poultry industry $300 million a year. The disease also causes chickens to have a skin color paler than they yellow color desired by consumers. With monoclonal antibodies produced by the ARS, Russell McCandliss and his colleagues at Genex Corp. of Rockville, Md., used genetic engineering to produce a characteristic protein of one major species of coccidia Coccidia /Coc·cid·ia/ (kok-sid´e-ah) a subclass of parasitic protozoa comprising the orders Agamococcidiida, Protococcidiida, and Eucoccidiida. . When injected into chickens, this experimental antigen stimulates production of antibodies, McCandliss says. Coccidial protozoans attack birds' intestinal tracts, killing them or weakening them by interfering with efficient feed conversion. Antigens of some coccidial species induce an immune response immune response n. An integrated bodily response to an antigen, especially one mediated by lymphocytes and involving recognition of antigens by specific antibodies or previously sensitized lymphocytes. that keeps the parasites from penetrating intestinal cells, while others cause the immune system immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. to block the parasites' development once they are inside cells. The ARS and Genex researchers do not yet know how the bioengineered antigen they are using works. ARS microbiologists Harry Danforth and Patricia C. Augustine used standard hybridoma hybridoma /hy·brid·o·ma/ (hi?brid-o´mah) a somatic cell hybrid formed by fusion of normal lymphocytes and tumor cells. hy·brid·o·ma n. (monoclonal antibody monoclonal antibody, an antibody that is mass produced in the laboratory from a single clone and that recognizes only one antigen. Monoclonal antibodies are typically made by fusing a normally short-lived, antibody-producing B cell (see immunity) to a fast-growing ) technology to develop antibodies that were then used by Genex to isolate coccidial antigens. The ARS researchers took spleen cells from mice that had been injected with coccidia and were producing antibodies against the parasites. They then fused the spleen cells with mouse cancer cells growing in cultures. The cancer cells reproduce rapidly, producing large amounts of the antibodies. Danforth cautions that the genetically engineered genetically engineered adjective Recombinant, see there antigen as it exists now provides only partial protection. He hopes further research can alter it to provide more complete protection. Other possibilities for introducing the coccidial antigen into birds, Danforth says, include isolating the gene coding for the antigen and inserting it into vaccinia viruses or putting the antigen into birds' feed or water. Direct insertion of the antigen gene coding for coccidial resistance in some chicken species is possible, but a long way off, he says. "We haven't considered cloning the gene and putting it into the chicken line yet, but that would be a very interesting prospect." |
|
||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion